Avasarala, J. 2018. DRESS Syndrome and Daclizumab Failure-Were Potentially Dangerous Signs Missed in Clinical Trials. Drug Target Insights. 12, 1 (Jun. 2018). DOI:https://doi.org/10.33393/dti.2018.1401.